Chemed (FRA:CXM) Total Operating Expense: €423 Mil (TTM As of Mar. 2026)


FRA:CXM Chemed Corp FRA:CXM
76 GF Score
Price €400.00
GF Value €567.34
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Chemed Total Operating Expense?

Chemed FRA:CXM -0.99% 76 Total Operating Expense is €423 Mil as of Mar. 2026. GuruFocus rates FRA:CXM with a GF Score™ of 76/100 and a GF Value™ of €567.34 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Chemed's Total Operating Expense for the three months ended in Mar. 2026 was €113 Mil. Chemed's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €423 Mil.

Chemed Total Operating Expense Related Terms

Chemed Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Chemed's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemed Total Operating Expense Chart

Chemed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 376.81 394.50 418.14 465.48 411.65

Chemed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 112.53 101.10 104.08 103.85 113.48
FRA:CXM
76GF Score
Chemed Corp FRA:CXM
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemed Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €423 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €423 Mil mean?
Chemed (FRA:CXM) has a Total Operating Expense of €423 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Chemed and its competitors.
Is Chemed's Total Operating Expense too high?
Chemed's current Total Operating Expense is €423 Mil. Overall, Chemed has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chemed's Total Operating Expense compare to PACS and LFST?
Chemed's Total Operating Expense of €423 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Healthcare Providers & Services company?
A good Total Operating Expense depends on the Healthcare Providers & Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Chemed and its competitors. Chemed's current Total Operating Expense is €423 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemed stock overvalued right now?
Based on GuruFocus' analysis, Chemed (FRA:CXM) is currently considered Modestly Undervalued. The stock's GF Value™ is €567.34, compared to a current price of €400.00 — trading 29.5% below its estimated fair value. The current Total Operating Expense is €423 Mil. Chemed's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Chemed (FRA:CXM), the current Total Operating Expense is €423 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemed (FRA:CXM) Overvalued in 2026?

Based on GuruFocus' analysis, Chemed stock appears to be undervalued. The current stock price of €400.00 is trading 29.5% below its estimated GF Value™ of €567.34. GuruFocus considers Chemed to be Modestly Undervalued.

Key valuation signals for FRA:CXM:

  • Total Operating Expense: €423 Mil
  • GF Value™: €567.34 vs. price of €400.00 (29.5% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the FRA:CXM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chemed Business Description

Other Exchanges CHE:USA
Address 255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
76GF Score

Get the complete analysis for FRA:CXM

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€400.00
Price
€567.34
GF Value